Browsing: Pharma

Kyowa Kirin has decided to halt all clinical development of its OX40 drug following the…

The design of modern research and development labs may need to be rethought. Artificial intelligence…

Outstanding trial results for the combination of Tekvayli and Darzalex Faspro in previously treated relapsed…

Since discontinuing two branded versions of its asthma inhaler Flovent in early 2024, GSK is…

Germany’s Merck KGaA, which achieved solid sales growth in a difficult 2025, could find itself…

Galderma significantly raised its annual peak sales forecast for Nemulvio (nemolizumab) to more than $4…

Leo Pharma has decided to launch the JAK inhibitor cream Anzupgo. The Danish pharmaceutical company,…

Vanda Pharmaceuticals’ seven-year ambition to expand the label for its sleeping drug Hetrios took an…

With significant manufacturing sites already under lockdown in China, CRDMO BioDuro is on a short…

Nearly four years after the lawsuit was filed, and against a backdrop of significant changes…